Drug efficacy sequence variation interpretation:Imp:Pt:Bld/Tiss:Ord:Molgen

Preferred Label : Drug efficacy sequence variation interpretation:Imp:Pt:Bld/Tiss:Ord:Molgen;

LOINC status : ACTIVE;

LOINC display name : Drug efficacy sequence variation interpretation Molgen Ql (Bld/Tiss) [Interp];

LOINC long common name : Genetic variation's effect on drug efficacy;

LOINC short name : Drug eff seq var interp-Imp;

LOINC description : Predicted phenotype for ability of drug to bind to intended site in order to deliver intended affect. A single marker interpretation value known to allow (responsive) or prevent (resistant) the drug to perform.;

Détails

Origin ID

51961-1;

UMLS CUI

C2360727;

Has component
- Drug [LOINC component]
- Drug efficacy sequence variation interpretation [LOINC component]
- Interpretation [LOINC component]
Has method
- Molecular genetics [LOINC method]
Has property
- Impression/interpretation of study [LOINC Property]
Has scale
- Ord [LOINC scale]
Has system
- Blood [LOINC System]
- Blood or Tissue [LOINC System]
- Tissue and Smears [LOINC System]
Has time aspect
- Point in time (spot) [LOINC time aspect]
Part of panel
- DNA analysis discrete sequence variation panel:-:Pt:Bld/Tiss:-:Molgen [LOINC code]
- DNA marker results panel:-:Pt:Bld/Tiss:-:Molgen [LOINC code]
- Individual allele results panel:-:Pt:Bld/Tiss:-:Molgen [LOINC code]
- Pharmacogenomics result panel:-:Pt:^Patient:-: [LOINC code]
Semantic type(s)
- Clinical Attribute [UMLS semantic type]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients